Company Monitoring Page for Actelion

latest headlines for company on cafepharma

Idorsia drug fails to quell binge eating in midphase trial, driving biotech to abandon the indication
Fierce Biotech
Tue, 05/10/22 - 10:39 am
Tags:
Idorsia, clinical trials, ACT-539313, binge eating disorder, Actelion
Top 10 pharma settlements since 2018
Fierce Pharma
Tue, 11/19/19 - 10:27 am
Tags:
settlements, Reckitt Benckiser, JNJ, Bayer, Allergan, Actelion, Purdue Pharma, Teva Pharmaceutical, Endo, Teikoku, Insys, Pfizer, GSK, Astellas, Amgen
Actelion inks $360M deal to resolve DOJ kickbacks probe
Fierce Pharma
Thu, 12/6/18 - 06:54 pm
Tags:
JNJ, DOJ, PAH, Actelion, kickbacks
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
Yahoo/Reuters
Mon, 06/18/18 - 09:47 am
Tags:
Indorsia, Actelion, JNJ, insomnia
FDA calls out 39 drug companies for allegedly blocking access to generics
Stat
Thu, 05/17/18 - 10:15 am
Tags:
JNJ, Actelion, Celgene, Gilead, Novartis, Pfizer, Valeant Pharmaceuticals, generics, FDA
J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout
Endpoints
Tue, 04/17/18 - 11:08 am
Tags:
JNJ, Actelion, antibiotics, C. difficile, cadazolid
Biotech sector ensures highest premium among M&A transactions
GoinPharma
Tue, 01/2/18 - 11:05 am
Tags:
biotech, M&A, Kite Pharma, Gilead Sciences, JNJ, Actelion
J&J adds PhIII hypertension drug to the pipeline with $230M-plus cash deal for Idorsia
Endpoints
Mon, 12/4/17 - 11:43 am
Tags:
JNJ, hypertension, Idorsia, Actelion
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
Mon, 08/14/17 - 10:03 am
Tags:
biotech, M&A, JNJ, Actelion, Takeda, Ariad Pharmaceuticals, Gilead Sciences, Pfizer, Amgen
Johnson & Johnson closes $30B Actelion buyout
Drug Delivery Business News
Fri, 06/16/17 - 10:16 am
Tags:
JNJ, Actelion, M&A
Johnson & Johnson wins last regulatory nod needed for Actelion acquisition
Drug Delivery Business News
Sat, 06/10/17 - 12:14 pm
Tags:
JNJ, Actelion, M&A, EU, Europe
Johnson & Johnson’s $30B buyout suffers setback as Actelion antibiotic fails in one phase 3, succeeds in another
Fierce Biotech
Thu, 06/8/17 - 09:38 am
Tags:
JNJ, Actelion, clinical trials, M&A, antibiotics, cadazolid
Minerva shares jump as J&J hands over $30M, revises insomnia drug pact; Iroko lays off 122
Endpoints
Sat, 06/3/17 - 09:17 am
Tags:
Minerva Neurosciences, MIN-202, JNJ, Actelion, insomnia, Iroko Pharmaceuticals
Johnson & Johnson: Help Me Actelion, You're My Only Hope
Barron's
Tue, 04/18/17 - 09:01 pm
Tags:
JNJ, Actelion, M&A, earnings
About that pharma M&A comeback? Sorry. 2017's not bringing it—at least not yet
Fierce Pharma
Mon, 04/10/17 - 10:19 am
Tags:
M&A, Stada, Shire, Baxalta, JNJ, Actelion, Mylan Labs, Pfizer, Takeda, Ariad Pharmaceuticals, Medivation
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
Tags:
JNJ, Actelion, Darzalex, Novartis, Cosentyx, Jakavi, Lucentis, Tasigna, Roche, Venclexta, Tecentriq, emicizumab
Actelion shareholders OK R&D spinout
Drug Delivery Business News
Wed, 04/5/17 - 12:04 pm
Tags:
Actelion, R&D, spinoffs, JNJ
JNJ Declares Success of Actelion Tender, Sees Closing in Second Quarter
TheStreet.com
Fri, 03/31/17 - 10:08 am
Tags:
JNJ, Actelion, M&A
4 Reasons Johnson & Johnson Surged 8% in February
Motley Fool
Thu, 03/2/17 - 03:46 pm
Tags:
JNJ, Darzalex, Actelion, Donald Trump
What's wrong with Sanofi's dealmaking approach? To hear Actelion tell it, plenty
Fierce Pharma
Fri, 02/17/17 - 10:01 am
Tags:
Sanofi, Actelion, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.